ArticleBiochemical pharmacology2007

Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).

Linda P Dwoskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.